These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 20374083)
1. Transforming growth factor beta2 level is elevated in neurons of Alzheimer's disease brains. Noguchi A; Nawa M; Aiso S; Okamoto K; Matsuoka M Int J Neurosci; 2010 Mar; 120(3):168-75. PubMed ID: 20374083 [TBL] [Abstract][Full Text] [Related]
2. TAG-1 is an inhibitor of TGFbeta2-induced neuronal death via amyloid beta precursor protein. Tachi N; Hashimoto Y; Nawa M; Matsuoka M Biochem Biophys Res Commun; 2010 Mar; 394(1):119-25. PubMed ID: 20184861 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein. Hashimoto Y; Chiba T; Yamada M; Nawa M; Kanekura K; Suzuki H; Terashita K; Aiso S; Nishimoto I; Matsuoka M Mol Cell Biol; 2005 Nov; 25(21):9304-17. PubMed ID: 16227582 [TBL] [Abstract][Full Text] [Related]
4. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. Kubo T; Nishimura S; Kumagae Y; Kaneko I J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice. Li WZ; Li WP; Yao YY; Zhang W; Yin YY; Wu GC; Gong HL Eur J Pharmacol; 2010 Feb; 628(1-3):108-15. PubMed ID: 19948164 [TBL] [Abstract][Full Text] [Related]
7. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Patil S; Sheng L; Masserang A; Chan C Neurosci Lett; 2006 Oct; 406(1-2):55-9. PubMed ID: 16904262 [TBL] [Abstract][Full Text] [Related]
8. Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo. Kim HS; Choi Y; Shin KY; Joo Y; Lee YK; Jung SY; Suh YH; Kim JH J Neurosci Res; 2007 May; 85(7):1528-37. PubMed ID: 17393484 [TBL] [Abstract][Full Text] [Related]
9. Death and survival of neuronal cells exposed to Alzheimer's insults. Niikura T; Hashimoto Y; Tajima H; Nishimoto I J Neurosci Res; 2002 Nov; 70(3):380-91. PubMed ID: 12391601 [TBL] [Abstract][Full Text] [Related]
10. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385 [TBL] [Abstract][Full Text] [Related]
11. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease. Boutillier S; Lannes B; Buée L; Delacourte A; Rouaux C; Mohr M; Bellocq JP; Sellal F; Larmet Y; Boutillier AL; Loeffler JP Neurodegener Dis; 2007; 4(6):413-23. PubMed ID: 17934324 [TBL] [Abstract][Full Text] [Related]
12. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. Funato H; Yoshimura M; Kusui K; Tamaoka A; Ishikawa K; Ohkoshi N; Namekata K; Okeda R; Ihara Y Am J Pathol; 1998 Jun; 152(6):1633-40. PubMed ID: 9626067 [TBL] [Abstract][Full Text] [Related]
14. Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478 [TBL] [Abstract][Full Text] [Related]
15. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207 [TBL] [Abstract][Full Text] [Related]
16. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease. Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255 [TBL] [Abstract][Full Text] [Related]
18. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Yu WF; Guan ZZ; Bogdanovic N; Nordberg A Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636 [TBL] [Abstract][Full Text] [Related]
19. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644 [TBL] [Abstract][Full Text] [Related]
20. Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease. Jin JK; Ahn BH; Na YJ; Kim JI; Kim YS; Choi EK; Ko YG; Chung KC; Kozlowski PB; Min do S Neurobiol Aging; 2007 Jul; 28(7):1015-27. PubMed ID: 16797788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]